Click to enlarge

Charlie Galvin

Charlie Galvin is General Manager for the UK, Ireland and Canada at Amicus Therapeutics.  

Prior to this Charlie gained a breadth of pharmaceutical experience in market access, policy, commercial management and marketing roles at Amgen and then Pfizer. Charlie is passionate about making the UK a world leader in science and innovation and that this translates into making a meaningful difference for patients.

Championing this agenda is her mission in her cross-industry roles as chair of the Rare Disease Industry Group, member of the ABPI Board and industry representative on the NICE methods review working group.